Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys. - Wikidata - wikimedia - TriplyDB

Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys.

Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys.

http://www.wikidata.org/entity/Q34120840

about

Nonhuman primate models for HIV/AIDS vaccine development Using nonhuman primates to model HIV transmission Tracking the luminal exposure and lymphatic drainage pathways of intravaginal and intrarectal inocula used in nonhuman primate models of HIV transmission A Multiplex Microsphere-Based Immunoassay Increases the Sensitivity of SIV-Specific Antibody Detection in Serum Samples and Mucosal Specimens Collected from Rhesus Macaques Infected with SIVmac239 Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants.Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide.Factors associated with siman immunodeficiency virus transmission in a natural African nonhuman primate host in the wild.New directions for HIV vaccine development from animal models.Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys.Molecularly tagged simian immunodeficiency virus SIVmac239 synthetic swarm for tracking independent infection events Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys.Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections Rapid, repeated, low-dose challenges with SIVmac239 infect animals in a condensed challenge window.Fcgbp - A Potential Viral Trap in RV144 SHIV susceptibility changes during the menstrual cycle of pigtail macaques.Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?A polyvalent Clade B virus-like particle HIV vaccine combined with partially protective oral preexposure prophylaxis prevents simian-human immunodeficiency virus Infection in macaques and primes for virus-amplified immunity Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users.Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia.Barriers to mucosal transmission of immunodeficiency viruses.Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4 The acute HIV infection: implications for intervention, prevention and development of an effective AIDS vaccine Simple mathematical models do not accurately predict early SIV dynamics Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.TRIM5α does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposure SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma.Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA.For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge.Innate immunity in acute HIV-1 infection Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys Generation and characterization of a SIVmac239 clone corrected at four suboptimal nucleotides.Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages.Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 va Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac2 Mucosal simian immunodeficiency virus transmission in African green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sites Differential innate immune responses to low or high dose oral SIV challenge in Rhesus macaques Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques

P2860

Q26861148-CD1132BE-6EB2-402A-90A9-28E901B790FE Q26861425-4DE16AD4-4E4E-4B87-A72B-D07D05385B6E Q27313356-23CD79A2-08BC-4FDC-92CC-4621104D0449 Q28383579-617541E5-ACA7-4ADD-84B9-98B6E9B067A4 Q30404569-E87E5C47-CC0B-47B6-80AA-35D4F6F936E7 Q30404738-A258C67E-2736-4B87-A443-298F6BCF40A2 Q33602718-DD01A5C6-9CD6-469F-AB04-89F510026A2E Q33767191-4F21C505-F5E0-404F-B72D-C55E797645DD Q33780980-DBFF21B7-67AA-4D6C-B78B-29FA86EF6C35 Q33900353-ED43E4ED-6EF3-409E-B8BB-736190AB156D Q34020988-16A9BC6F-BDB9-44F6-8E7B-C39ADF541A19 Q34042642-C78B63AE-E6E5-47F0-A289-769B0982367C Q34108798-81ACC1CF-EB5A-4B19-9A12-E55D879DF15A Q34201287-C315FB6D-25D3-47D8-8308-CCCF3B3686BB Q34243579-9CB5E1B1-C20A-4EF6-8701-C1B6E91F322A Q34379806-F61D980E-D60C-4505-9C19-5B191A0C5909 Q34399535-AC35C0BA-7CD9-4AB4-AD17-3107D8931CCD Q34630446-DC24A4F6-F844-4D9A-895F-C984028844CB Q34802271-DC29CDD3-56F6-4B7B-9447-7A1095AC8F50 Q35105449-47859BF5-8FF7-4FE8-8CB1-4F402CA6CDF7 Q35140968-C09B8A6B-4DD8-4047-9B08-1A4397739FD9 Q35172385-97F9BD2B-C8FD-4FE6-8ACD-2FB1506B47B7 Q35200862-E2127E9D-998C-4CD3-9804-069E299D05F8 Q35232811-FD939289-4E11-4D2F-8E53-6BACDF59947F Q35487807-689F2D24-B59F-4EFA-90C5-2FE3A955A7B6 Q35531415-0D52731E-2237-462D-9B2A-77F2AD68169A Q35581949-A32A25AB-8242-40ED-A56C-F1916833C5CE Q35658952-00E8DB4B-F63C-4D35-A756-20B7EC7FC5C7 Q35665770-0DB810D6-75BB-426C-8C71-9126FEF11DFB Q35665851-B50BAF23-4FBC-4E55-A1F1-6B5349D5E137 Q35667426-BDD1A45C-0935-429C-8011-918D9D16E5DD Q35696991-57079978-D922-4077-9FD0-0F0AC60E346B Q35729899-1CCA17BD-ADE6-4A5C-A856-4FA38A6CB019 Q35748138-DC732FC6-CF23-4FBF-A0AB-49B78FBE927E Q35826158-7444BDBB-5BEE-4B5E-AAEB-53FDDD32560E Q35826525-522553D3-554F-4E89-A689-664843D9A7F8 Q35867976-6548D1B8-D9CF-44EF-980F-520E14368C19 Q35868061-78BB0EF0-9882-451B-9088-769E6A44DA8F Q35915659-312693B0-67AA-4B68-ACD7-1E3207623C36 Q35927290-CC14721D-BBF0-4F17-BC1E-82A829201D8B

P2860

Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys.

http://www.wikidata.org/entity/Q34120840

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Low-dose mucosal simian immuno ...... us variants in rhesus monkeys.

@ast

Low-dose mucosal simian immuno ...... us variants in rhesus monkeys.

@en

Low-dose mucosal simian immuno ...... us variants in rhesus monkeys.

@nl

type

label

Low-dose mucosal simian immuno ...... us variants in rhesus monkeys.

@ast

Low-dose mucosal simian immuno ...... us variants in rhesus monkeys.

@en

Low-dose mucosal simian immuno ...... us variants in rhesus monkeys.

@nl

prefLabel

Low-dose mucosal simian immuno ...... us variants in rhesus monkeys.

@ast

Low-dose mucosal simian immuno ...... us variants in rhesus monkeys.

@en

Low-dose mucosal simian immuno ...... us variants in rhesus monkeys.

@nl

P1433

Q34120840-74C39B5E-9EBF-490D-8482-055275E51C12

P1476

Q34120840-E53CCBD4-19BA-4CCD-86B4-C7AF90333DF5

P2093

Q34120840-2D55A1A0-90B4-4F77-8578-038A791FF0F3

Q34120840-66079014-08EE-417F-B01A-E688773176F5

Q34120840-8E3435E3-5580-47DE-B98E-76C31C22A4B7

Q34120840-936E64EA-B89C-4D66-8825-A5CBAA234C58

Q34120840-BAF32E59-DDFA-47AB-AE58-393C9766D419

Q34120840-F75D5B60-F5F2-411D-A810-CD4C07FE426B

Q34120840-FE370AAB-DE1A-4288-A47D-19A1B3F4403E

Q34120840-FEB06C10-D1AA-49B4-8C25-0590FF56607F

P2860

Q34120840-12F5CC97-21A2-4B82-83BA-C47BA6806CAF

Q34120840-1CFB9978-B84F-43A3-B7F5-29E15EDD5EED

Q34120840-2C27CDCE-FCC7-4409-95AF-05DAD1A25A3D

Q34120840-34D38665-8412-4DBA-A4F8-F5A9DC564437

Q34120840-410EFE2E-72B1-4924-9650-F69E7261628F

Q34120840-43F6E87C-DC5E-4409-A6A2-C015C47F6A2A

Q34120840-4E2ECCF3-0BCD-4B7D-A451-FD9E26E3C3D2

Q34120840-62219C7F-A752-4A75-8111-6E442BD668E4

Q34120840-6C1DADED-3507-40DB-B37A-46C367791AE6

Q34120840-8832B851-4246-45E8-887E-1B48B928CEDE

P304

Q34120840-BE936313-EC9D-40B8-BB4F-741BD589232D

P31

Q34120840-961453A2-D402-4283-9CB0-06C7F3D10DCB

P356

Q34120840-F36760FE-A23F-46FF-B7C3-74059CCEC2A0

P407

Q34120840-9379B6D5-0B5E-4B2D-8B80-20A8778035F5

P433

Q34120840-5A8F1222-49EB-43D0-ABF7-1CD0E6366C5E

P478

Q34120840-F0C9E8BC-BB8C-4465-9441-4ECB2D41F37E

P50

Q34120840-00F61028-921C-455D-866B-0AC8670DBF82

Q34120840-600BB514-8B0C-4878-A721-0BE7BB301957

Q34120840-A8192D7F-8F8A-498F-BFA1-AEAAA7B88BCC

Q34120840-E03FD5AF-1078-4810-B167-BE817369455B

Q34120840-E6D5E2B6-86A9-4045-A1FA-8815CA4CF3B7

Q34120840-F80B1130-24B5-43AB-BCF9-63E7E972D44B

P577

Q34120840-4B24A380-28FD-44FC-A357-28FE88894B17

P698

Q34120840-6B0782CE-80EE-4BF7-8887-712DD224632B

P921

Q34120840-FE643CE2-ACE3-4EBB-8F92-352C14AFC667

P932

Q34120840-F466C16D-C079-4742-AB45-4AC74DA4BED8

P356

P1433

Journal of Virology

P1476

Low-dose mucosal simian immuno ...... us variants in rhesus monkeys.

@en

P2093

Angela Carville

http://www.w3.org/2001/XMLSchema#string

Dror Kolodkin-Gal

http://www.w3.org/2001/XMLSchema#string

Georgia D Tomaras

http://www.w3.org/2001/XMLSchema#string

Hui Li

http://www.w3.org/2001/XMLSchema#string

Jinyan Liu

http://www.w3.org/2001/XMLSchema#string

Keith G Mansfield

http://www.w3.org/2001/XMLSchema#string

Norman L Letvin

http://www.w3.org/2001/XMLSchema#string

Philip J Norris

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial

Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.

Wide variation in the multiplicity of HIV-1 infection among injection drug users

A limited number of simian immunodeficiency virus (SIV) env variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251.

Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239

P304

10406-10412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01155-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Beatrice H. Hahn

P577

2010-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20686016

http://www.w3.org/2001/XMLSchema#string

P921

Simian immunodeficiency virus

P932

2937794

http://www.w3.org/2001/XMLSchema#string